Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?

Ventilator associated pneumonia(VAP) is a severe complication that can lead to high mortality when not early identified or when therapy is delayed. The aim of this study was to evaluate procalcitonin(PCT) as a biomarker for VAP development. In total, 73 hospitalized patients with COVID-19 were analy...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Diagn Microbiol Infect Dis
Main Authors: Côrtes, Marina Farrel, de Almeida, Bianca Leal, Espinoza, Evelyn Patricia Sanchez, Campos, Aléia Faustina, do Nascimento Moura, Maria Luiza, Salomão, Matias C., Boszczowski, Icaro, Freire, Maristela Pinheiro, de Carvalho, Laina Bubach, Paranhos-Baccalà, Gláucia, Costa, Silvia Figueiredo, Guimarães, Thaís
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Inc. 2021
נושאים:
Clinical Studies
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879055/
https://ncbi.nlm.nih.gov/pubmed/34243136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diagmicrobio.2021.115344
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים